Structural and functional characterization of USP47 reveals a hot spot for inhibitor design
© 2023. Springer Nature Limited..
USP47 is widely involved in tumor development, metastasis, and other processes while performing a more regulatory role in inflammatory responses, myocardial infarction, and neuronal development. In this study, we investigate the functional and biochemical properties of USP47, whereby depleting USP47 inhibited cancer cell growth in a p53-dependent manner-a phenomenon that enhances during the simultaneous knockdown of USP7. Full-length USP47 shows higher deubiquitinase activity than the catalytic domain. The crystal structures of the catalytic domain, in its free and ubiquitin-bound states, reveal that the misaligned catalytic triads, ultimately, become aligned upon ubiquitin-binding, similar to USP7, thereby becoming ready for catalysis. Yet, the composition and lengths of BL1, BL2, and BL3 of USP47 differ from those for USP7, and they contribute to the observed selectivity. Our study provides molecular details of USP47 regulation, substrate recognition, and the hotspots for drug discovery by targeting USP47.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
---|---|
Enthalten in: |
Communications biology - 6(2023), 1 vom: 22. Sept., Seite 970 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shin, Sang Chul [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 3.4.19.12 |
---|
Anmerkungen: |
Date Completed 25.09.2023 Date Revised 19.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s42003-023-05345-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362365105 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362365105 | ||
003 | DE-627 | ||
005 | 20231226091103.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s42003-023-05345-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1207.xml |
035 | |a (DE-627)NLM362365105 | ||
035 | |a (NLM)37740002 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shin, Sang Chul |e verfasserin |4 aut | |
245 | 1 | 0 | |a Structural and functional characterization of USP47 reveals a hot spot for inhibitor design |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.09.2023 | ||
500 | |a Date Revised 19.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. Springer Nature Limited. | ||
520 | |a USP47 is widely involved in tumor development, metastasis, and other processes while performing a more regulatory role in inflammatory responses, myocardial infarction, and neuronal development. In this study, we investigate the functional and biochemical properties of USP47, whereby depleting USP47 inhibited cancer cell growth in a p53-dependent manner-a phenomenon that enhances during the simultaneous knockdown of USP7. Full-length USP47 shows higher deubiquitinase activity than the catalytic domain. The crystal structures of the catalytic domain, in its free and ubiquitin-bound states, reveal that the misaligned catalytic triads, ultimately, become aligned upon ubiquitin-binding, similar to USP7, thereby becoming ready for catalysis. Yet, the composition and lengths of BL1, BL2, and BL3 of USP47 differ from those for USP7, and they contribute to the observed selectivity. Our study provides molecular details of USP47 regulation, substrate recognition, and the hotspots for drug discovery by targeting USP47 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Ubiquitin-Specific Peptidase 7 |2 NLM | |
650 | 7 | |a EC 3.4.19.12 |2 NLM | |
650 | 7 | |a Ubiquitin |2 NLM | |
650 | 7 | |a USP7 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.19.12 |2 NLM | |
700 | 1 | |a Park, Jinyoung |e verfasserin |4 aut | |
700 | 1 | |a Kim, Kyung Hee |e verfasserin |4 aut | |
700 | 1 | |a Yoon, Jung Min |e verfasserin |4 aut | |
700 | 1 | |a Cho, Jinhong |e verfasserin |4 aut | |
700 | 1 | |a Ha, Byung Hak |e verfasserin |4 aut | |
700 | 1 | |a Oh, Yeonji |e verfasserin |4 aut | |
700 | 1 | |a Choo, Hyunah |e verfasserin |4 aut | |
700 | 1 | |a Song, Eun Joo |e verfasserin |4 aut | |
700 | 1 | |a Kim, Eunice EunKyeong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Communications biology |d 2018 |g 6(2023), 1 vom: 22. Sept., Seite 970 |w (DE-627)NLM284287245 |x 2399-3642 |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2023 |g number:1 |g day:22 |g month:09 |g pages:970 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s42003-023-05345-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 6 |j 2023 |e 1 |b 22 |c 09 |h 970 |